Loeb & Loeb and Mori Hamada & Matsumoto have advised NASDAQ-listed SPAC (special purpose acquisition company) Pono Capital Two on its $1.2 billion de-SPAC merger with Japan’s SBC Medical Group Holdings.
This merger is aimed at expansion of its business network globally, SBC said in a statement. After the completion of the merger, SBC will change its name to SBC Medical Group.
Nishimura & Asahi has advised Japanese life insurance giant Dai-ichi Life Holdings on its 2.9-trillion-yen ($2 billion) acquisition of healthcare platform Benefit One, which was represented by Mori Hamada & Matsumoto.
Leading Japanese law firm Mori Hamada & Matsumoto has announced that it will establish a presence in Yokohama, the nation’s second-largest city. It will be the firm’s seventh domestic office.
Clifford Chance and Nishimura & Asahi have acted for private equity firm CVC Capital Partners on its 17-billion-yen ($1.2 billion) acquisition of Sogo Medical Group, Japan’s fifth-biggest pharmacy by store numbers. Sogo was represented by Mori Hamada & Matsumoto.